Diabeloop key facts
as of Oct 2026- Developer of an AI-based blood sugar monitoring device designed to improve diabetes treatment.
- Diabeloop is valued at approximately $57.1M as of Oct 2026 (last reported valuation).
- It has raised $141.3M; the latest was Later Stage VC ($630K) in Mar 2025.
- Notable investors include UI Investissement, Supernova Invest, Turenne Groupe, Crédit Agricole Alpes Développement, Odyssee Venture — 25 tracked in total.
- Status: Privately Held (backing).
Diabeloop's last reported valuation, Sep 2019. Nothing priced has surfaced since.
- ·The complete investor list: 25 names
- ·Watch Diabeloop: the Monday email on marks, rounds and moves
Diabeloop funding rounds
No funding rounds for Diabeloop are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Diabeloop
25+Diabeloop valuation
Diabeloop's last reported valuation was $57.1 million in Sep 2019. No priced round, secondary trade or fund mark has surfaced since.
Diabeloop investors
25 investors are on record for Diabeloop, including UI Investissement, Supernova Invest, Turenne Groupe and Crédit Agricole Alpes Développement. By type, the record holds 4 private equity firms and 1 venture capital firm.
About Diabeloop
Developer of an AI-based blood sugar monitoring device designed to improve diabetes treatment. The company's device automatically delivers the appropriate dose of insulin to patients and has a sensor that measures patients' glucose levels, a pump that delivers insulin, and a smartphone application with an embedded algorithm and patient interface that links the sensor and the pump, enabling patients to have a lighter mental load and live their lives without interruptions.
- Sector
- Healthcare
- HQ
- Grenoble, France
- Founded
- 2015
- Employees
- 87
- Website
- diabeloop.fr/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.